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Abstract
Folate receptors have two glycosyl phosphatidylinositol anchored isomers, alpha and
beta. Folate receptor alpha binds with high affinity for folic acid and act as a receptor for
mediated transport of folate into the cells. Folate is necessary for DNA metabolism and thus it is
speculated that rapidly dividing cancer cells have an increased necessity for folic acid. Folate
receptor alpha levels eminent in specific malignant diseases (like solid tumors and leukemia) and
thus folate receptors serve in the detection of FR+ (Folate receptor positive) and diagnosis of
cancers1-3.
In general, liposomes have the capacity intake the most imaging and toxic agents due to
their large diameter size (100nm). In the liposomal system, the most important thing for
therapeutic activity is the conjugation between the liposome and folic acid due to the:
1. Need to present folate to the cancer cell surface unfettered from the bulky liposome (in
order to bind to the folate surface).
2. Need to have sufficient folate ligands for proficient binding to cell but not much more
folate molecules that could result in non-specific binding.
In the liposomal system, folate is attached to poly ethylene glycol (PEG), which is
incorporated into the lipid membrane by way of a hydrophobic tail. Although widely established,
liposomes require a fair degree of technical ability to synthesize and analyze. Recently, it has
been revealed that apoferritin (iron transport protein), 450 kD polymeric protein (at 70 nm in
diameter), is capable of being dissociated into its respective subunits at low pH 2 and reassociated at pH around 8.5 to restructure the apoferritin cage for therapeutic purposes. Based on
all these results, our project aim is to synthesize a folate based apoferritin probe4-5. The type of
folate conjugation to the apoferritin, the degree of folate labeling to the protein, the quantity of
5

dye incorporation into the protein cage and type of dye, drugs and other agents will be assessed
and ultimately be tested for cell uptake. These types of cages are useful for the production of
radio-imaging agents, MRI contrast agents and some drug delivery systems. The main goal of
this project is to make an economical and easily produced folate probe that will be substituted for
more costly and cumbersome liposome delivery vehicles6.

Introduction
New Clinical research presents the importance of folate receptor in the targeted drug
delivery system. Targeted deliveries via selective cellular marker can increase the usefulness and
diminish the toxicity of therapeutic drugs. Folate receptors are richly present in cancer cells,
helping to deliver the chemotherapeutic agents at specific sites of action and also preventing to
rich in to the healthy cell. The most important thing for therapeutic activity of the drug is the
folate receptor drug delivery system link between the drug and folic acid. Strong bonds like
amide show no or little activity whereas weak bonds like disulfide bonds show strong activity7-8.
Folic Acid:
Folic acid (vitamin B9) is a water soluble vitamin (see figure 1). The human body requires
folic acid to generate healthy red blood cells and prevent anemia. Folic acid is important for cell
division and growth. Folic acid itself is inactive in the body but the reduced form of folic acid is
tetrahydrofolate that essentially important in the metabolic reactions of the body. It helps in fetal
development in pregnant women as it develops cells of the fetus. It is also important as a
coenzyme in the synthesis of DNA and RNA9-10.
Folate is required in the metabolism of amino acids like histidine, serine, glycine and
methionine. If folate is not present in methionine metabolism, homocysteine builds up. Excess
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amount of homocysteine increases the risk of various diseases, particularly cardiovascular
disease. Homocysteine metabolism also needs vitamin B12 and vitamin B6. Folic acid with
vitamin B12 causes the conversion of homocysteine to methionine, reducing the blood levels of
homocysteine and decreasing the risk of heart diseases11. Deficiency of folic acid may create
many health problems such as impaired DNA synthesis, cancer development, and cardiovascular
disease12. Normal diets including leafy foods, liver products, and cereals contain high amounts of
natural folate and may decrease the risk of cancer13.
Apoferritin cages:
Apoferritin is nothing but ferritin not combined with iron. Apoferritin is composed of the
same protein shell as ferritin, but it’s core is empty. Apoferritin has protein spheres found mainly
in the liver and spleen, research interests has increased due to interesting structure features and
biological properties. Apoferritin is a native protein containing 24 subunits of polypeptide that
interact to gather to form a hollow cage like structure with a 12.5 nm diameter. The interior
cavity of apoferritin has approximately an 8 nm diameter and an interior volume capacity up to
4500 iron atoms as an iron oxide hydroxide mineral. Apoferritin channels formed by subunit
interactions with diameter of 3-4 A0, connect with each other at the outside of the apoferritin
molecule6, 14.
The apoferritin cage can be dissociated into 24 subunits at pH 2 and subunits reconstitute
at high pH 8.5. Apoferritin, having unique cavity structure as well as its dissociation and
reconstitution characteristics, has been widely used as a protein cage to synthesize size restricted
bioinorganic nanocomposite, e.g., cobalt, manganese, iron sulfide, iron phosphate, cadmium
sulfide, uranium. The application of the synthesized bioinorganic nanocomposite include
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magnetic resonance imaging, radio pharmaceutical, quantum dots, nanobatteries, uranium
neutron captured therapy, photo catalysts and magnetic memory devices15.
Appearance of folate receptor:
The α, β and γ are the three main isoforms of folate receptor. The most widely expressed
isoforms of folate receptor are α and β. The folate receptor α is expressed at high levels in
several tissues that include; proximal tubules in the kidney, pneumocytes, intestinal membrane
and placenta16-17. The folate receptor β is expressed in low to reasonable amounts in normal
tissues.
Folate receptors in the cells
Folate receptor α is a glycophosphatidylinositol (GPI) membrane bound protein having
high affinity for folic acid and transport receptor mediated folate in the cells (see figure-2).
Folate is a basic component for DNA synthesis and its repair. It is hypothesized that rapidly
dividing cancer cells have an increased requirement for folate to maintain DNA synthesis 18.
Folate receptors α level are high in specific malignant tumors of epithelial origin compared to
normal cells. Folate receptors are over expressed on some cancer cell types but present in low
abundance in non cancerous tissue. Based on this over expression of the folate receptor, folate
based drug delivery and diagnostic systems are in several stages of development19-20.
Folate targeted Apoferritin cages:
Folate targeted apoferritin cages can be made in two different ways;
1. First, apoferritin cages are loaded with folate cysteine and then the pH is lowered to 2 by
adding 0.1M HCl. Fluorescein sample is loaded into it and pH rises to 8.5 by adding
0.1M NaOH, The apoferritin cages would trap the fluorescein during reconstitution (see
figure-13).
8

2. Another way is the apoferritin cage can be dissociated by lowering pH to 2 by adding
0.1M HCl and loading it with fluorescein sample and then increasing the pH by adding
0.1M NaOH and loading it with folate cysteine, as the last step.
The apoferritin surface has exposed lysine residue. The lysine residue can be coupled with
folate by combination of a hetero bifunctional crosslinker like SPDP with subsequent addition of
folate cysteine. We established specific strategy to join folic acid to the apoferritin molecule.

Materials, Methods and Instruments
Materials and reagents:
Apoferritin: Apoferritin from Equine spleen, 2.2 ml – 48mg protein/ml, Lot # A3641
Apoferritin from Horse spleen, 25 mg/ml in 50% glycerol & 0.075M NaCl.
Phosphate Buffer Saline (PBS): Mediatech Inc, Manassas, VA 20109, Lot # 21040174
Cat no. 21-040-CV; BCA 1-1 kit: Bicinchoninic Acid kit for protein determination, Sigma
Aldrich, Lot # 059K9801, Bicinchonic Acid Solution: Batch # 118K5300, Copper (II) Sulfate
Solution: Batch # C2282 (25ml); SPDP (N- Succinimidyl – 3-(2-Pyridyldithio) Propionate,
Pierce, Lot # HB101395, Prod # 21857; DMSO: Sigma Aldrich, 99% purity, Batch # 11696 DK;
Fluorescence Sodium Salt (C20H10Na2O5): Sigma-Aldrich, Lot # 079K0141V; Folate Cysteine:
Provided by Dr. Henne; Water: B & J brand, Lot # CZ 360; Multichannel Pipette : RAININ, 20300µl; UV Plate: BD Falcon micro test 96 well 370µl clear plate, UV – VIS transparent film
bottom, Non-sterile, Lot # E10002007; Regular plate: Generic Bio-One – micro plate, 96 each
well with flat bottom, Lot # E091006L (see figure-11); Spin Filters: Sigma Aldrich, Amicon
ultra 0.5 centrifugal filter, Batch # 3110; PD-10 Column: Sephadex G-25M column, contains
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0.15% Kathon CG in distilled water, Lot # 393861; Centrifuge: Beckman CS-15R and new one
Thermo scientific Sorvall Legend Micro 17 Ventilated micro centrifuge with 24 place rotor,
120VAC (see figure-7); UV plate reader and BCA assay Software: Gen 5.1.10 Biotech, Epoch;
Ocean optics USB 2000+ (for fluorescence study); Ocean optics PX-2, pulsed xenon light
source; 1 cm cuvette holder .

Methodology
SPDP labeling with folate cysteine:
SPDP (N-Succinimidyl–3-(2-Pyridyldithio)-propionate) reagent is an amine and sulfhydryl
reactive heterobifunctional crosslinker. It forms amine-amine or amine-sulfhydryl crosslinker
with molecules. Folic acid links with apoferritin cage by heterobifunctional crosslinker SPDP
(see figure-12). Weight 0.0021gm of SPDP dissolved in 380µl of DMSO. Take only 50µl of this
solution (SPDP+DMSO) and add to apoferritin sample (100µl of Apoferritin + 400µl of PBS). It
is allowed to react for 1 hour. After completion of this reaction, the protein cage purifies from
excess SPDP using spin filters. Spin it for 4 to 5 times with PBS and extracted with PBS
(Sample-1). Weigh 1.6mg of folate and quickly dissolve in DMSO. Mix this sample with
sample-1. Again spin it for 4-5 times and extract with H2O. Determination of folic acid on the
protein was measured in UV-Vis plate at 363nm.
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• Take 100µl of Apoferritin sample and dilute it to 400µl with PBS
• Wash it twice with PBS
• Take 21mg of SPDP and dilute it with 380µl of DMSO
• Add this solution to the mixture of apoferritin and PBS sample
• Place on magnetic stirrer for 1 hour
• Wash it 4 times and extract with PBS

• Weigh 16mg of folate cysteine and quickly dissolve in DMSO
• Mix this solution with the extracted solution of protein
• Spin it 4 times with dis. H2O and extract with dis. H2O
• Next step is the fluorescein loading

Fluorescein Loading:
Fluorescein loading can be done either with folate or without folate for different purposes.
First dilute 100µl of apoferritin sample into 400µl of PBS. Wash 3 times with PBS to get rid of
glycerol. Lower the pH of the solution by 2 by adding 0.1M HCl. Load the fluorescein and stand
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the solution for approximately 15 minutes. Again raise the pH to 8.5 by adding 0.1M NaOH. The
next step is BCA assay.

1
2

• Take 100µl of Apoferritin sample and dilute it with 400µl of dis. H 2O
• Spin and filter it three times with PBS and keep it magnetic stirring

3

• Take 20mg of fluorescein and dilute it with 5ml dis.H2O(10mM). Make
10 fold sample (total volume 500µl).

4

• After three washes, lower the apoferritin solution's pH~2 by adding
156µl of 0.1M HCl

5
6
7

8
9
10

• Add 50µl of fluorescein solution to the apoferritin solution
• Allow to stand for half an hour
• Raise the pH of the solution to 8.5 by adding 140µl of NaOH
• Magnetic stir for 2 hours
• Spin 4 times with PBS and extract with PBS or run through PD 10
column

• Do the BCA Assay for collected fractions

Fluorescence study:
Determination of loading amount of marker (fluorescence sodium salts) in apoferritin can
be done by simple fluorescence study. The number of entrapped fluorescence was estimated by
12

calibrating the ratio of concentration of fluorescence and apoferritin. Bicinchoninic acid method
can be used for the apoferritin concentration measurement. The fluorescein content in apoferritin
can be determined by comparing fluorescence intensities of the fluorescein Marker-Loaded
apoferritin nanoparticles with standard fluorescein solution. By measuring fluorescence
intensities of fluorescein solution at different concentrations, a calibration curve for the standard
fluorescein was developed6.
Preparation of different dilutions of fluorescein sodium salt:

1
2
3
4
5
6
7

• Weigh 1.9mg of fluorescein and dissolve into 5ml of PBS (Sample-1)
• Sample-2: Take 500µl from sample-1 & add 4.5ml of PBS
• Sample-3: Take 500µl from sample-2 & add 4.5ml of PBS
• Sample-4: Take 1ml from sample-3 & add 4ml of PBS
• Sample-5: Take 1ml from sample-4 & add 4ml of PBS
• Sample-6: Take 1ml from sample-4 & add 1ml of PBS
• Sample-7: Take 1ml fromsample-5 & add 1ml of PBS

BCA Assay:
The apoferritin concentration can be measured by using the bicinchoninic acid method.
BCA protein assay is a detergent compatible formulation based on BCA for colorimetric
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detection and quantitation of protein. Bovine serum albumin (BSA) stock solution was taken
from ampoule and different dilutions prepared as per Thermo Scientific Pierce BCA protein
assay instructions. Prepare different dilutions 2000µg/ml, 1500µg/ml, 1000µg/ml, 750µg/ml,
500µg/ml, 250µg/ml, 125µg/ml, 25µg/ml and 0µg/ml for BCA assay. By using 96-micowell
plate, take 10µl of each standard solution as well as unknown by duplicates in each well. Then
added 200µl of the working prepared solution (10ml of BCA solution and 200µl of Cu (II)
sulphate solution and mixed it in a tube). Incubate the 96-microwell plate for half an hour and
find out the concentration by using the BCA Assay Gen 5.0 software (see figure-11).

Results and Discussion
Folate Labeling:
The method used here for folate labeling with SPDP crosslinker was straightforward and
quick. Labeling of protein with folate was carried out with specific concentration of folate by
using SPDP crosslinker. With the molar extinction coefficient of folic acid at pH 7.5, we
determined the degree of folate labeling was approximately 100. There were 4 exposed lysine
units found on the apoferritin cage surface which means approximately 96 (4*24) residues were
conjugatable. Our results explain that we could label approximately 96 sites and almost got full
folate labeling (see figure-13).
BCA Assay:
Bicinchoninic acid method was used for the measurement of apoferritin concentration.
This method employs the reduction of Cu+2 to Cu+1 by protein in alkaline medium with the
highly selective and sensitive colorimetric detection of the Cu+1 by using bicinchoninic acid
reagent. The chelation of two molecules of BCA with Cu+1 creates a purple colored reaction that
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absorbs at 562nm. The amount of product formed is nearly linear with increasing protein
concentrations over a broad working range (0 - 1500µg/ml).
Upon final purification using the spin filter method, the compound was analyzed for
protein concentration using BCA assay. Based on the BCA assay reading, we determined the
apoferritin concentration to be 2191mg/ml (see figure-11 and figure-14).
Fluorescein Loading (Fluorescence Study):
The ratio of the concentrations of markers (fluorescein sodium salt and Methylene blue)
and apoferritin cage can help to estimate the number of entrapped markers. Attempts to increase
the loading of fluorescein sodium salt have been undertaken.
By using the concentration of protein from BCA assay and concentration of fluorescein
from fluorescence study, we determined fluorescein loading of 1 or 2
A calibration curve for the standard fluorescein was developed by measuring fluorescence
intensities at the different concentration of fluorescein. We got liner graph (R2 = 0.9992) with
fluorescence study (see figure-18 and figure-19).

Conclusions:
Folate labeling and fluorescein loading with apoferritin is prepared using a very
straightforward and secure methodology using very simple instrumentations. First we conjugated
folate to the apoferritin cage and then determined the degree of labeling to the protein. Purified
protein cages were loaded with folate using spin filters. We attempted to load the protein with
fluorescein dye and determined the degree of dye incorporation. We tried to trap the fluorescein
with apoferritin cage by using different concentrations. We succeeded in fluorescence
spectroscopy by using different concentration of fluorescein.
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Future Studies
Increase fluorescein loading and test the apoferritin protein cages with folate receptor positive
cancer cells.
Load the apoferritin cage with other agents such as methylene blue for photodynamic therapy
and/or chemotherapeutic agents such as cis-platin.
Funding
This project was funded by combination of personal funds of Dr.Henne A. Walter (HTT
Company) and the Chemistry Department of Governors State University.
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Figure 1: Structure of folic acid

Figure 2: Folate receptor pathway and FR-mediated endocytosis of a folic acid drug conjugates.
Folate conjugates bind folate receptor with high affinity and then internalized into endosomes
that can reduce disulfide bonds. (Figure taken from Accounts of chemical research 120-129
January 2008 Vol. 41, No.1)
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Figure 3: Comparison of alpha-FR on normal cells and malignant cells. (Endocyte Inc.)

Figure 4: SPDP Structure

Figure 5: DMSO (Dimethyl Sulfoxide)
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Figure 6: Fluorescein Sodium Salt (C20H10Na2O5)

Figure 7: Thermo scientific Sorvall Legend Micro 17 Ventilated micro centrifuge with 24 place
rotor, 120VAC (8898 RPM for 12 minutes)
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Figure 8: pH meters

Figure 9: Magnetic Stirrer
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Figure 10: Folate labeling and fluorescein loading to apoferritin cage after final spin filter.

Figure 11: Generic Bio-One, 96-microwell plate, after 1 hour incubation while doing BCA
Assay
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Figure 12: SPDP Labeling and folate labeling
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Figure 13: Folate labeling and fluorescein loading with apoferritin
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Figure 15: UV-Vis Spectrum of apoferritin
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